According to David Ornstein of The Athletic, Chelsea is on the verge of completing the signing of Nicolas Jackson, who was also a target for Tottenham. The Senegal international has undergone a successful medical examination in London, paving the way for his move to Chelsea.
Initially, it was reported by The Sun that Spurs were considering making a bid for the Villarreal player this summer. However, Chelsea has now overtaken their London rivals in the race to secure Jackson’s signature. The 22-year-old forward has already agreed to personal terms with Chelsea after the club triggered his €35 million (£30 million) release clause.
Sky Sports reports that Chelsea is paying slightly more than the release clause demands, although the additional amount will be spread across several instalments instead of being paid upfront. This approach is likely to help Chelsea comply with Financial Fair Play regulations.
With the player’s contract finalized, a fee agreed upon, and the medical examination completed, Chelsea is expected to announce the signing of Nicolas Jackson in the near future. Fabrizio Romano has confirmed that the striker will sign an eight-year contract with the club.
However, there are warnings about the expectations placed on Jackson, especially if he is expected to be Chelsea’s main striker for the 2023/24 season. European football expert Kevin Hatchard cautions that while Jackson has shown promise at Villarreal in recent months, he lacks a significant track record at the senior level. Hatchard suggests that if Jackson is brought in as a squad player, he can compete effectively, but if he is immediately thrust into the role of the team’s primary center-forward, it may be a risky move.
While it will undoubtedly be a significant step up for Jackson, Chelsea’s decision-makers evidently believe in his potential and are confident in his ability to succeed at the club.